RxDoctor Payments Data

Lindsey Wondoloski

Psychiatric/Mental Health · Knoxville, TNNPI 1912664053

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 407 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,380, more than ten times the $21 reported in 2021. Among psychiatric/mental health clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,636in general payments, 2019–2025

Across 407 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$854
  • Teva Pharmaceuticals USA, Inc.$811
  • Neurocrine Biosciences, Inc.$708
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$655
  • Alkermes, Inc.$636
  • AbbVie$628
  • plus $3K from 19 others

What the payments were for

  • Food & beverage$7,623100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,636 in reported general payments places this provider in the 95th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl19$32,570
RexultiBrexpiprazole14$19,791
LybalviOlanzapine/Samidorphan Malate13$19,784
CaplytaLumateperone Tosylate12$17,975
TrintellixVortioxetine Hydrobromide11$6,094
Vilazodone Hcl24$1,509
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine21$1,349
Lurasidone Hcl20$1,098
Aripiprazole19$1,029
Desvenlafaxine Succinate ErDesvenlafaxine Succinate22$971
Bupropion XlBupropion Hcl26$739
Propranolol Hcl34$680
Duloxetine Hcl29$634
Buspirone Hcl48$482
Quetiapine Fumarate32$454

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$628$32,57019 claims
Otsuka America Pharmaceutical, Inc.Rexulti$854$19,79114 claims
Alkermes, Inc.Lybalvi$636$19,78413 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$655$17,97512 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$479$6,09411 claims
Almatica Pharma LLCSertraline Hcl$190$9619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →